Source: Scripps Research Institute
Posted: May 17, 2006
Summary:
A team of scientists at The Scripps Research Institute has published a new study of important signaling pathways that are required for the expansion of pancreas stem cells, work that may lead to strategies to prevent or reverse insulin-dependent diabetes mellitus (IDDM), or Type 1 diabetes.
Commentary: This study hopefully will give scientists a better understanding of how to possibly apply pancreas stem cells to treat patients with Type 1 diabetes
No comments:
Post a Comment